IP Library Granted Patent US 8,136,520
Granted Patent B2
US 8,136,520 · App. 12/687,805 · Granted Mar 20, 2012

Occlusion device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,136,520
App. No.
12/687,805
Granted
Mar 20, 2012
Kind
B2
Abstract

An obturator for a bronchial tube or tubule of a human or animal lung includes a blocking element ( 92 ) and a securing element ( 90 ). The blocking element serves to seal the tube or tubule against the passage of fluid past the obturator when the obturator is disposed in a bronchial tube or tubule. The securing element serves to retain the blocking element in position. The blocking element comprises a substantially cylindrical plug of biocompatible, resiliently deformable closed-cell foamed plastics material, such as PVC. The securing element includes a stent having barbs ( 98 ) to engage and retain the blocking element. The stent also has anchors ( 100 ) to retain the stent in a bronchial tube or tubule. A method of treatment of emphysema or other lung conditions or diseases in human or animal patients comprises placing an obturator in a bronchial tube or tubule of the patient so as to seal the tube or tubule against the passage of fluid past the obturator.

Claims (17)

1. A method for treating a patient having an abnormal permanent enlargement in a section of the lung distal to a bronchial tube, said method comprising:

isolating the section of the lung so that no air can be drawn into said section and the isolated section deflates in time as the air remaining in said section becomes absorbed, wherein said section stops affecting other areas of the lung which can then perform normally, wherein isolating comprises implanting an obturator in the bronchial tube.

2. A method as in claim 1 , wherein the obturator is placed by a device inserted through the mouth and trachea of the patient to a proposed placement site in the bronchial tube.

3. A method as in claim 1 , wherein the obturator comprises a blocking element and a securing element, wherein the blocking element seals the bronchial tube and the securing element retains the blocking element at the placement site in the bronchial tube.

4. A method as in claim 3 , wherein the securing element comprises a compressible framework which is capable of expanding within the bronchial tube.

5. A method as in claim 4 , wherein the blocking element comprises a cylindrical plug of biocompatible material.

6. A method as in claim 5 , wherein the biocompatible material comprises a resiliently deformable closed-cell foamed plastic.

7. A method as in claim 5 , wherein the biocompatible material comprises a resiliently deformable closed-cell foamed plastic.

8. A method as in claim 4 , wherein the blocking element comprises a cylindrical plug of biocompatible material.

9. A method as in claim 1 , wherein isolating comprises forming a complete seal which prevents leakage during inhalation and pressurization of the lung.

10. A method as in claim 1 , wherein isolating comprises the obturator expanding to form a complete seal which prevents leakage during inhalation and pressurization of the lung.

11. A method for treating a patient having an abnormal permanent enlargement in a section of the lung distal to a bronchial tube, said method comprising:

providing an obturator in a compressed state at a distal end of a delivery device;

advancing the delivery device through a mouth of a patient, down the patient's trachea and into the bronchial tube;

ejecting the obturator from the delivery device, wherein the obturator expands at a proposed placement site in the bronchial tube for isolating and deflating lung.

12. A method as in claim 11 , wherein the obturator comprises a blocking element and a securing element, wherein the blocking element seals the bronchial tube and the securing element retains the blocking element at the placement site in the bronchial tube.

13. A method as in claim 12 , wherein the securing element comprises a compressible framework which is capable of expanding within the bronchial tube.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: SABANATHAN, THIRUMANI; BRADFORD HOSPITALS NHS TRUST; FOUNDRY, LLC, THE
To: EMPHASYS MEDICAL, INC.
Reel/Frame 035726/0408 →
SUPPLEMENT TO AGREEMENT OF JUNE 6, 2000 Recorded May 27, 2015
From: SABANATHAN, THIRUMANI; BRADFORD HOSPITALS NHS TRUST AND THE FOUNDRY, LLC
To: EMPHASYS MEDICAL, INC.
Reel/Frame 035792/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: SABANATHAN, THIRUMANI; BRADFORD HOSPITALS NHS TRUST
To: FOUNDRY, LLC, THE
Reel/Frame 035726/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2015
From: EMPHASYS MEDICAL, INC.
To: PULMONX
Reel/Frame 035726/0446 →